提供Tdbcons 葡聚糖,聚蔗糖及其衍生产品
Tdbcons公司位于瑞典乌普萨拉,成立于1990年,主要研究和生产葡聚糖及其相关产品。后来产品线扩大到聚蔗糖、菊粉、透明质酸及粘多糖等。产品主要用于疫苗生产、结肠炎造模、血细胞分离,、及药品缓释等生物医药领域。Tdbcons 是GE,AMAG 等公司的合作伙伴,常年为期提供产品及技术咨询服务。
货号 | 产品名称 | 产品简介 | 规格 | 应用 | 品牌 |
QD150 | Q-dextran 150 | Q-葡聚糖(Mw:150000) | 10 g | 疫苗佐剂 | Tdbcons |
QD70 | Q-dextran 70 | Q-葡聚糖(Mw:70000) | 10 g | 疫苗佐剂 | Tdbcons |
QD40 | Q-dextran 40 | Q-葡聚糖(Mw:40000) | 10 g | 疫苗佐剂 | Tdbcons |
QD20 | Q-dextran 20 | Q-葡聚糖(Mw:20000) | 10 g | 疫苗佐剂 | Tdbcons |
QD4 | Q-dextran 4 | Q-葡聚糖(Mw:4000) | 10 g | 疫苗佐剂 | Tdbcons |
P1000 | Polysucrose 1000 | 聚蔗糖/Ficoll 1000000 | 1 g | 分离 | Tdbcons |
P40 | Polysucrose 40 | 聚蔗糖/Ficoll 40000 | 1 g | 分离 | Tdbcons |
P20 | Polysucrose 20 | 聚蔗糖/Ficoll 20000 | 1 g | 分离 | Tdbcons |
DP70 | DEAE-Polysucrose 70 | DEAE-纤维素聚蔗糖/Ficoll 70000 | 1 g | Tdbcons | |
DD2000 | DEAE-dextrans 2000 | DEAE-纤维素葡聚糖 (Mw:2000000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD500 | DEAE-dextrans 500 | DEAE-纤维素葡聚糖 (Mw:500000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD150 | DEAE-dextrans 150 | DEAE-纤维素葡聚糖 (Mw:150000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD70 | DEAE-dextrans 70 | DEAE-纤维素葡聚糖 (Mw:70000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD20 | DEAE-dextrans 20 | DEAE-纤维素葡聚糖 (Mw:20000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD10 | DEAE-dextrans 10 | DEAE-纤维素葡聚糖 (Mw:10000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
DD4 | DEAE-dextrans 4 | DEAE-纤维素葡聚糖 (Mw:4000) | 10 g | 疫苗佐剂,蛋白稳定剂,转染 | Tdbcons |
CMP70 | Carboxymethyl-Polysucroses 70 | 羧甲基聚蔗糖/Ficoll(Mw: 70000) | 1 g | Tdbcons | |
CMD150 | Carboxymethyl-dextran 150 | 羧甲基葡聚糖(Mw: 150000) | 10 g | 结合阳离子的试剂 | Tdbcons |
CMD70 | Carboxymethyl-dextran 70 | 羧甲基葡聚糖(Mw: 70000) | 10 g | 结合阳离子的试剂 | Tdbcons |
CMD40 | Carboxymethyl-dextran 40 | 羧甲基葡聚糖(Mw: 40000) | 10 g | 结合阳离子的试剂 | Tdbcons |
CMD20 | Carboxymethyl-dextran 20 | 羧甲基葡聚糖(Mw: 20000) | 10 g | 结合阳离子的试剂 | Tdbcons |
CMD4 | Carboxymethyl-dextran 4 | 羧甲基葡聚糖(Mw: 4000) | 10 g | 结合阳离子的试剂 | Tdbcons |
PhD40 | Phenyl-dextran 40 | 苯基葡聚糖(Mw: 40000) | 10 g | 制备疏水凝胶 | Tdbcons |
DB051 | Dextran sulphate 500LS | 硫酸葡聚糖(Mw: 500000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB015 | Dextran sulphate 100LS | 硫酸葡聚糖(Mw: 100000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB003 | Dextran sulphate 40LS | 硫酸葡聚糖(Mw: 40000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB013 | Dextran sulphate 20LS | 硫酸葡聚糖(Mw: 20000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB009 | Dextran sulphate 10LS | 硫酸葡聚糖(Mw: 10000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB005 | Dextran sulphate 5LS | 硫酸葡聚糖(Mw: 5000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB050 | Dextran sulphate 500 | 硫酸葡聚糖(Mw: 500000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB0016 | Dextran sulphate 100 | 硫酸葡聚糖(Mw: 100000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB0012 | Dextran sulphate 20 | 硫酸葡聚糖(Mw: 20000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB008 | Dextran sulphate 10 | 硫酸葡聚糖(Mw: 10000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB004 | Dextran sulphate 5 | 硫酸葡聚糖(Mw: 5000) | 10 g | 稳定剂,酶激活或抑制剂,抗病毒制剂 | Tdbcons |
DB001 | Dextran sulfate sodium (DSS) for colitis | 葡聚糖硫酸钠盐 | 50 g | 结肠炎造模 | Tdbcons |
BD2000 | Blue-Dextran 2000 | 汽巴蓝F3GA标记葡萄聚糖(Mw:500000) | 1 g | 层析 | Tdbcons |
BD500 | Blue-Dextran 500 | 汽巴蓝F3GA标记葡萄聚糖(Mw:110000) | 1 g | 层析 | Tdbcons |
BD110 | Blue-Dextran 110 | 汽巴蓝F3GA标记葡萄聚糖(Mw:70000) | 1 g | 层析 | Tdbcons |
B70 | Blue-Dextran 70 | 汽巴蓝F3GA标记葡萄聚糖(Mw:40000) | 1 g | 层析 | Tdbcons |
B40 | Blue-Dextran 40 | 汽巴蓝F3GA标记葡萄聚糖(Mw:20000) | 1 g | 层析 | Tdbcons |
BD20 | Blue-Dextran 20 | 汽巴蓝F3GA标记葡萄聚糖(Mw:10000) | 1 g | 层析 | Tdbcons |
BD10 | Blue-Dextran 10 | 汽巴蓝F3GA标记葡萄聚糖(Mw:5000) | 1 g | 层析 | Tdbcons |
BD5 | Blue-Dextran 5 | 1 g | |||
TP400 | TRITC-Polysucroses 400 | TRITC标记聚蔗糖/FITC-Ficoll 400000 | 100 mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
TP70 | TRITC-Polysucroses 70 | TRITC标记聚蔗糖/FITC-Ficoll 70000 | 100 mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
TP40 | TRITC-Polysucroses 40 | TRITC标记聚蔗糖/FITC-Ficoll 40000 | 100 mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
TP20 | TRITC-Polysucroses 20 | TRITC标记聚蔗糖/FITC-Ficoll 20000 | 100 mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
TD2000 | TRITC-Dextran 2000 | TRITC标记葡聚糖(Mw:2000 ) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD500 | TRITC-Dextran 500 | TRITC标记葡聚糖(Mw:400000-600000 ) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD150 | TRITC-Dextran 150 | TRITC标记葡聚糖(Mw:140000-170000) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD70 | TRITC-Dextran 70 | TRITC标记葡聚糖(Mw:70000 ) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD40 | TRITC-Dextran 40 | TRITC标记葡聚糖(Mw:35000-45000 ) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD20 | TRITC-Dextran 20 | TRITC标记葡聚糖(Mw:18000-25000 ) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
TD4 | TRITC-Dextran 4 | TRITC标记葡聚糖(Mw:3000-4000) | 100 mg | 微循环及膜穿透率研究 | Tdbcons |
THA-Se | T-hyaluronic acid | TRITC标记透明质酸 | 100 mg | Tdbcons | |
FDSS40 | FITC-Dextran sulfate 500 | FITC标记葡聚糖硫酸纳 (Mw:400000-650000) | 100mg | 结肠炎研究 | Tdbcons |
FDSS40 | FITC-Dextran sulfate 40 | FITC标记葡聚糖硫酸纳 (Mw:30000-50000) | 100mg | 结肠炎研究 | Tdbcons |
FDP400 | FITC-DEAE-Polysucrose 400 | FITC标记DEAE-纤维素聚蔗糖 (Mw:350000-450000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FDP70 | FITC-DEAE-Polysucrose 70 | FITC标记DEAE-纤维素聚蔗糖 (Mw:60000-80000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FCMP400 | FITC-CM-Polysucrose 400 | FITC标记羧甲基葡聚糖 (Mw:350000-450000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FCMP70 | FITC-CM-Polysucrose 70 | FITC标记羧甲基聚蔗糖 (Mw:60000-80000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FP400 | FITC-Polysucrose 400 | FITC标记聚蔗糖/FITC-Ficoll 400000 | 100mg | 细胞渗透,肾小球膜渗透研究 | Tdbcons |
FP70 | FITC-Polysucrose 70 | FITC标记聚蔗糖/FITC-Ficoll 70000 | 100mg | 细胞渗透,肾小球膜渗透研究 | Tdbcons |
FP40 | FITC-Polysucrose 40 | FITC标记聚蔗糖/FITC-Ficoll 40000 | 100mg | 细胞渗透,肾小球膜渗透研究 | Tdbcons |
FP20 | FITC-Polysucrose 20 | FITC标记聚蔗糖/FITC-Ficoll 20000 | 100mg | 细胞渗透,肾小球膜渗透研究 | Tdbcons |
FI | FITC-Inulin | FITC标记菊粉(Mw:4000) | 100mg | 肾清除率研究 | |
FDD150 | FITC-DEAE-dextran 150 | FITC标记DEAE-纤维素葡聚糖 (Mw:160000-190000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FDD70 | FITC-DEAE-dextran 70 | FITC标记DEAE-纤维素葡聚糖 (Mw:70000-90000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FDD40 | FITC-DEAE-dextran 40 | FITC标记DEAE-纤维素葡聚糖 (Mw:40000-60000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FDD20 | FITC-DEAE-dextran 20 | FITC标记DEAE-纤维素葡聚糖 (Mw:20000-30000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FDD4 | FITC-DEAE-dextran 4 | FITC标记DEAE-纤维素葡聚糖 (Mw:3000-6000) | 100mg | 膜运输,及细胞、组织穿透性研究 | Tdbcons |
FD2000 | FITC-Dextran 2000000 | FITC标记葡聚糖 (Mw:2000000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD500 | FITC-Dextran 500000 | FITC标记葡聚糖 (Mw:500000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD150 | FITC-Dextran 150000 | FITC标记葡聚糖 (Mw:150000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD110 | FITC-Dextran 110000 | FITC标记葡聚糖 (Mw:110000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD70 | FITC-Dextran 70000 | FITC标记葡聚糖 (Mw:70000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD40 | FITC-Dextran 40000 | FITC标记葡聚糖 (Mw:40000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD20 | FITC-Dextran 20000 | FITC标记葡聚糖 (Mw:20000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD10 | FITC-Dextran 10000 | FITC标记葡聚糖 (Mw:10000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FD4 | FITC-Dextran 4000 | FITC标记葡聚糖 (Mw:4000) | 100mg | 微循环及膜穿透率研究 | Tdbcons |
FCMD150 | FITC-CM-dextran 150 | FITC标记羧甲基葡聚糖 (Mw:160000-200000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FCMD70 | FITC-CM-dextran 70 | FITC标记羧甲基葡聚糖 (Mw:70000-95000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FCMD40 | FITC-CM-dextran 40 | FITC标记羧甲基葡聚糖 (Mw:40000-60000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FCMD20 | FITC-CM-dextran 20 | FITC标记羧甲基葡聚糖 (Mw:20000-30000) | 100mg | 细胞及膜功能研究 | Tdbcons |
FCMD4 | FITC-CM-dextran 4 | FITC标记羧甲基葡聚糖 (Mw:4000-6500) | 100mg | 细胞及膜功能研究 | Tdbcons |